After the recent action against Snapdeal for selling prescription drugs online, the future of online pharmacies has become a question mark. Former national advisor (drugs control) and former Karnataka drugs controller, Dr. BR Jagashetty said “Online sale of drugs can be permitted only with strict norms. Also, stringent guidance should be formulated in the amendment bill, 2015 of Drugs & Cosmetics Act & Rules. As computerization and technology is making services convenient, India being recognized worldwide for its IT potential, and availability of options for doctor’s appointment, accessing lab reports, payments, purchases is now transforming to online, the sale of drugs online can also co-exit but with strict rules.”
The scheme would be like US and EU who already have regulations for online pharmacies. In US, the online pharmacy should be certified by Verified Internet Pharmacy Practice Sites (VIPPS) and EU has issued a common logo for legally operating online pharmacies/retailers. “The rules for online pharmacies in India should be framed on priority by the CDSCO, which should have a yearly renewal method. With a growing geriatric population, who needs constant action of medication, online pharmacies are seen to be way forward in India. Presently, the government is keen on transforming the operations computerized to ensure efficiency and transparency, the Ministry of Health and Family Welfare should consider the same.” Dr Jagashetty added.
Other News
High-Value Medical Equipment: Customs Exemptions
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC – Special Expert Committee
The Central Drugs Standard Control Organization (CDSCO) has recently published an article titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read More
